Tricyclic compounds

A compound represented by the formula (I) ÄA represents a 5- to 7-membered hydrocarbon ring group; L represents -NR -CO-, -CO-NR - and the like (R represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KENJI ASAI, KOZO AOKI, FUKUICHI OHSAWA, KAZUNOBU TAKAHASHI, NOBUKAZU KAKUI, NAOMI TAKEI, YUJI TABATA, NAOYUKI NISHIKAWA, JIRO TANAKA, MAKOTO SUZUKI, MASAHARU SUGAI, AKIHIKO IKEGAWA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KENJI ASAI
KOZO AOKI
FUKUICHI OHSAWA
KAZUNOBU TAKAHASHI
NOBUKAZU KAKUI
NAOMI TAKEI
YUJI TABATA
NAOYUKI NISHIKAWA
JIRO TANAKA
MAKOTO SUZUKI
MASAHARU SUGAI
AKIHIKO IKEGAWA
description A compound represented by the formula (I) ÄA represents a 5- to 7-membered hydrocarbon ring group; L represents -NR -CO-, -CO-NR - and the like (R represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents -S-, -O-, -NR -, -NR -CO- and the like (R and R represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R , R and R represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the likeÜ or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU3840000A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU3840000A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU3840000A3</originalsourceid><addsrcrecordid>eNrjZBAOKcpMrkzOyUxWSM7PLcgvzUsp5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hxhYmBkDgaExYBQC8ux-8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Tricyclic compounds</title><source>esp@cenet</source><creator>KENJI ASAI ; KOZO AOKI ; FUKUICHI OHSAWA ; KAZUNOBU TAKAHASHI ; NOBUKAZU KAKUI ; NAOMI TAKEI ; YUJI TABATA ; NAOYUKI NISHIKAWA ; JIRO TANAKA ; MAKOTO SUZUKI ; MASAHARU SUGAI ; AKIHIKO IKEGAWA</creator><creatorcontrib>KENJI ASAI ; KOZO AOKI ; FUKUICHI OHSAWA ; KAZUNOBU TAKAHASHI ; NOBUKAZU KAKUI ; NAOMI TAKEI ; YUJI TABATA ; NAOYUKI NISHIKAWA ; JIRO TANAKA ; MAKOTO SUZUKI ; MASAHARU SUGAI ; AKIHIKO IKEGAWA</creatorcontrib><description>A compound represented by the formula (I) ÄA represents a 5- to 7-membered hydrocarbon ring group; L represents -NR -CO-, -CO-NR - and the like (R represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents -S-, -O-, -NR -, -NR -CO- and the like (R and R represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R , R and R represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the likeÜ or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.</description><edition>7</edition><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20001102&amp;DB=EPODOC&amp;CC=AU&amp;NR=3840000A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20001102&amp;DB=EPODOC&amp;CC=AU&amp;NR=3840000A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KENJI ASAI</creatorcontrib><creatorcontrib>KOZO AOKI</creatorcontrib><creatorcontrib>FUKUICHI OHSAWA</creatorcontrib><creatorcontrib>KAZUNOBU TAKAHASHI</creatorcontrib><creatorcontrib>NOBUKAZU KAKUI</creatorcontrib><creatorcontrib>NAOMI TAKEI</creatorcontrib><creatorcontrib>YUJI TABATA</creatorcontrib><creatorcontrib>NAOYUKI NISHIKAWA</creatorcontrib><creatorcontrib>JIRO TANAKA</creatorcontrib><creatorcontrib>MAKOTO SUZUKI</creatorcontrib><creatorcontrib>MASAHARU SUGAI</creatorcontrib><creatorcontrib>AKIHIKO IKEGAWA</creatorcontrib><title>Tricyclic compounds</title><description>A compound represented by the formula (I) ÄA represents a 5- to 7-membered hydrocarbon ring group; L represents -NR -CO-, -CO-NR - and the like (R represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents -S-, -O-, -NR -, -NR -CO- and the like (R and R represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R , R and R represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the likeÜ or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAOKcpMrkzOyUxWSM7PLcgvzUsp5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hxhYmBkDgaExYBQC8ux-8</recordid><startdate>20001102</startdate><enddate>20001102</enddate><creator>KENJI ASAI</creator><creator>KOZO AOKI</creator><creator>FUKUICHI OHSAWA</creator><creator>KAZUNOBU TAKAHASHI</creator><creator>NOBUKAZU KAKUI</creator><creator>NAOMI TAKEI</creator><creator>YUJI TABATA</creator><creator>NAOYUKI NISHIKAWA</creator><creator>JIRO TANAKA</creator><creator>MAKOTO SUZUKI</creator><creator>MASAHARU SUGAI</creator><creator>AKIHIKO IKEGAWA</creator><scope>EVB</scope></search><sort><creationdate>20001102</creationdate><title>Tricyclic compounds</title><author>KENJI ASAI ; KOZO AOKI ; FUKUICHI OHSAWA ; KAZUNOBU TAKAHASHI ; NOBUKAZU KAKUI ; NAOMI TAKEI ; YUJI TABATA ; NAOYUKI NISHIKAWA ; JIRO TANAKA ; MAKOTO SUZUKI ; MASAHARU SUGAI ; AKIHIKO IKEGAWA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU3840000A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KENJI ASAI</creatorcontrib><creatorcontrib>KOZO AOKI</creatorcontrib><creatorcontrib>FUKUICHI OHSAWA</creatorcontrib><creatorcontrib>KAZUNOBU TAKAHASHI</creatorcontrib><creatorcontrib>NOBUKAZU KAKUI</creatorcontrib><creatorcontrib>NAOMI TAKEI</creatorcontrib><creatorcontrib>YUJI TABATA</creatorcontrib><creatorcontrib>NAOYUKI NISHIKAWA</creatorcontrib><creatorcontrib>JIRO TANAKA</creatorcontrib><creatorcontrib>MAKOTO SUZUKI</creatorcontrib><creatorcontrib>MASAHARU SUGAI</creatorcontrib><creatorcontrib>AKIHIKO IKEGAWA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KENJI ASAI</au><au>KOZO AOKI</au><au>FUKUICHI OHSAWA</au><au>KAZUNOBU TAKAHASHI</au><au>NOBUKAZU KAKUI</au><au>NAOMI TAKEI</au><au>YUJI TABATA</au><au>NAOYUKI NISHIKAWA</au><au>JIRO TANAKA</au><au>MAKOTO SUZUKI</au><au>MASAHARU SUGAI</au><au>AKIHIKO IKEGAWA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Tricyclic compounds</title><date>2000-11-02</date><risdate>2000</risdate><abstract>A compound represented by the formula (I) ÄA represents a 5- to 7-membered hydrocarbon ring group; L represents -NR -CO-, -CO-NR - and the like (R represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents -S-, -O-, -NR -, -NR -CO- and the like (R and R represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R , R and R represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the likeÜ or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU3840000A
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Tricyclic compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T20%3A57%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KENJI%20ASAI&rft.date=2000-11-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU3840000A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true